What you'll find on this page
- Discover the features that may help you hear clearer sound.
- How SmartSound® iQ technology adapts to different environments.
Our sound philosophy
Our commitment to sound, through Human Design, is key to the quality of sound you can experience with our products. The aim of the Human Design concept is to adapt the technology to function in harmony with the body and its natural hearing pathways to deliver a full, natural sound experience for the brain to interpret.
Hearing clear, rich and natural sound1 may help you fully experience your environment and know what’s happening around you. It may help you hear sounds you have been missing and better locate where they came from or it can help you identify specific actions such a key turning a lock.
Every day, you move through several different hearing environments—and your sound processor should adapt automatically, so you can experience the sound around you to the fullest.
Better sound quality²
The Baha system lets you experience clear, rich and natural sound.1 It manages feedback to produce less distortion3 and actively works to reduce unwanted noise.
The Cochlear Baha 6 Max Sound Processor helps you access a broad and dynamic range of sounds which may improve your ability to understand speech in noisy situations.4
Sound processors that adapt to your world
Cochlear™ Baha® sound processors feature advanced technology3 that adapts automatically to your environment. This way, the subtle differences of sound are provided to you, so you only need to focus on the situation you’re in.
SmartSound iQ technology is designed to automatically reduce the noise that can impact your ability to hear in different situations.
How it works:
- SmartSound iQ technology analyses your surroundings and identifies the listening environment as one of seven scenes.
- The technology adjusts and optimises sound automatically to deliver clear sound in different environments.1
- The signal processing features work to deliver clear sound by enhancing speech, reducing noise and increasing comfort.
Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
Views expressed are those of the individual. Consult your health professional to determine if you are a candidate for Cochlear technology.
In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.
In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.
In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 10 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.
For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.
Any testimonial featured on this website is intended for an Australian audience only.
- Hoffman J. Subjective evaluation of clear rich and natural sound. Cochlear Bone Anchored Solutions AB, Sweden. 2020; D1788013.
- Hedin A, Andersson J, Hoffman J, Björk T, Flynn M. Summary of the Cochlear(TM) Baha(r) 5 Clinical development test results. Cochlear Bone Anchored Solutions AB, 630206, 2015
- Flynn MC. Smart and Small – innovative technologies behind the Cochlear Baha 5 Sound Processor. Cochlear Bone Anchored Solutions AB, 629761, 2015.
- Gawliczek T, Wimmer W, Caversaccio M, Kompis M. Influence of maximum power output on speech understanding with bone anchored hearing systems. Acta Otolaryngol. 2020;140(3):225-229.